ARTICLES LIST

Clear Search

Select the Article Source National Cancer Institute Office of Dietary Supplements National Institute on Aging Healthfinder.gov National Institute of Child Health and Human Development Centers for Disease Control and Prevention Administration for Children and Families National Institute of Environmental Health Sciences National Library of Medicine National Institute of Allergy and Infectious Diseases National Center for Complementary and Integrative Health National Institute of Neurological Disorders and Stroke NIH Senior Health National Institute of Arthritis and Musculoskeletal and Skin Diseases Health and Human Services National Institute of General Medical Sciences National Institute of Dental and Craniofacial Research National Human Genome Research Institute Food and Drug Administration Center for Tobacco Products Public Health and Medical Emergency Support for a Nation Prepared Office of Disease Prevention and Health Promotion, Healthy People National Institute on Drug Abuse National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases U S Food and Drug Administration National Institute on Deafness and Other Communication Disorders National Heart, Lung, and Blood Institute

Media ID	Source Name	Media Type	Language	Media Name	Media Description	Keywords	Keywords	Link to Article
1148	Centers for Disease Control and Prevention	Html	en	Announcements: Report Available on Ensuring the Safety andEffectiveness of Laboratory Data in Electronic Health RecordSystems	Electronic health record (EHR) systems can improve patient care by making it easier to collect, share, and interpret patient data. However, variations in EHR system design, functionality, and ability to exchange data accurately (interoperability) can cause preventable patient safety risks. The Clinical Laboratory Improvement Advisory Committee (CLIAC) of the U.	Health Record Systems 0.622422 endorsement 0.37179 patient data 0.503111 Human Services 0.736487 U.S. Department 0.72902 MMWR HTML versions 0.56009 Clinical Laboratory Improvement 0.615767 usability 0.418657 electronic PDF version 0.555295 way EHR systems 0.857543 development 0.347939 preventable patient safety 0.617157 Contact GPO 0.466671 laboratory data-related interoperability 0.640419 data integrity 0.592082 commercial sources 0.444345 patient care 0.472681 current prices 0.438261 original paper copy 0.541631 EHR technology 0.699932 electronic health record 0.870476 laboratory information 0.483899 EHR system design 0.756197 original MMWR paper 0.554567	U.S. Government Printing 0.55163 Informatics Workgroup 0.467538 health information technology 0.820983 information technology decision-making 0.57915 MMWR readers 0.449551 character translation 0.436597 Advisory Committee 0.457662 focus areas 0.591385 laboratory professionals 0.481708 EHR systems 0.986908 laboratory expertise 0.479247 format errors 0.448156 innovation 0.347535 typeset documents 0.443836 trade names 0.444448 official text 0.434788 information technology infrastructure 0.574577 non-CDC sites 0.442416 laboratory data–related errors 0.611294 organizations 0.347061 new report 0.45717 CDC report 0.517732 laboratory data 0.716622 electronic conversions 0.441156	CLICK HERE
4530	Centers for Disease Control and Prevention	Html	en	Flu Information for Schools	CDC recognizes that school administrators, teachers, staff, and parents are concerned about the flu, particularly its effects on children - CDC	flu symptoms 0.623479 different flu virus 0.661679 flu cough 0.6616 injectable influenza vaccines 0.485569 flu infection 0.607114 flu vaccine 0.85367 different flu viruses 0.678402 flu complications 0.735832 flu vaccines 0.693942 Vaccine Benefits 0.475251 influenza virus infection 0.470135 quadrivalent flu shot 0.651195 different age groups 0.50576 young children 0.465256 flu vaccination 0.659452 yearly flu vaccine 0.70489 main flu viruses 0.675677 spray flu vaccine 0.693151 influenza vaccine 0.511033 flu outcomes 0.660376 influenza vaccines 0.516379 Influenza vaccine options 0.510171 flu spreads 0.614506 antiviral drugs 0.674143	Quadrivalent flu vaccines 0.65799 seasonal flu vaccine 0.736071 flu viruses 0.75104 Different flu shots 0.652783 flu prevention messages 0.693944 people 0.536304 flu 0.975679 Trivalent flu vaccines 0.663772 recombinant influenza vaccines 0.484766 CDC Flu Information 0.656695 flu share 0.638561 nasal spray vaccine 0.520994 flu shot 0.665454 stomach flu 0.644897 illness milder 0.487714 influenza viruses 0.491284 regular flu shot 0.650382 high risk 0.560521 main influenza viruses 0.485583 different flu 0.683898 flu season 0.637533 Cold Versus Flu 0.670476 Influenza antiviral drugs 0.491699	CLICK HERE
4856	Centers for Disease Control and Prevention	Html	en	Ventilator-associated Pneumonia FAQs - HAI	null	nose 0.207505 healthcare community 0.489594 germs 0.236832 CDC 0.340326 surveillance methods 0.519392 device-associated infections 0.648357 ventilator-associated pneumonia 0.994264 bloodstream infections 0.721684	tube 0.303562 mouth 0.204512 patient breathe 0.575868 Network Patient Safety 0.810022 lungs 0.22292 National Healthcare Safety 0.815628 oxygen 0.201898	CLICK HERE
5380	Centers for Disease Control and Prevention	Html	en	FASD - The Danish Medical Research Council -- Copenhagen, Denmark - International Research	FASDs are 100% preventable if a woman does not drink alcohol during pregnancy. There is no known safe amount of alcohol to drink while pregnant. There is also no safe time during pregnancy to drink and no safe kind of alcohol.	Falgreen Eriksen HL 0.527143 early pregnancy 0.717446 moderate alcohol intake 0.593536 binge drinking 0.693931 5-year-old children 0.555483 early pregnancy increase 0.500867 Gynaecology 0.520113 Denny CH 0.567686 psychomotor deficits 0.511985 children 0.579686 year-old children 0.45675 Eriksen H-LF 0.475316 pre-pregnancy alcohol drinking 0.555174 prenatal alcohol exposure 0.82008 EL 0.527197 growth retardation 0.46104 moderate prenatal alcohol 0.634239 different alcohol drinking 0.546506 nervous system problems 0.463003 binge drinking episodes 0.521529 Medical Research Council 0.506911 telephone survey 0.459814 International Journal 0.800036 BJOG 0.48861 Bertrand J. 0.462398	population-based cohort study 0.524136 Danish National Birth 0.586948 nervous system development 0.462267 heavy alcohol 0.512086 read summary 0.969935 alcohol binge drinking 0.552609 National Birth Cohort 0.6 Experimental Research 0.497325 1-6. DOI 0.495312 Falgreen Eriksen H-L 0.693261 mid pregnancy 0.456306 medical information 0.456169 facial abnormalities 0.459794 prospective cohort study 0.50629 intellectual information 0.456263 moderate alcohol consumption 0.712806 Eriksen HL 0.588133 Obstetrics 0.507035 Underbjerg 0.455362 child neuropsychological functioning 0.497896 nervous system vulnerabilities 0.461991 Medical Research Archives 0.497616 Pregnancy Study Group 0.496925 Landrø NI 0.62247	CLICK HERE
6419	Centers for Disease Control and Prevention	Html	en	Vital Signs: HIV Prevention Through Care and Treatment - United States	Background: An estimated 1.2 million persons in the United States were living with human immunodeficiency virus (HIV) infection in 2008. Improving survival of persons with HIV and reducing transmission involve a continuum of services that includes diagnosis (HIV testing), linkage to and retention in HIV medical care, and ongoing HIV prevention interventions, including appropriately timed antiretroviral therapy (ART).	ART 0.293844 new HIV infections 0.285306 HIV testing strategy 0.26592 United States 0.819888 national HIV incidence 0.257361 antiretroviral therapy 0.247436 HIV-infected persons 0.302855 national hiv 0.352394 HIV prevalence 0.350287 regular HIV care 0.289815 HIV prevalence rates 0.307358 National HIV Surveillance 0.299926 prevention counseling 0.350266 New York City 0.330635 ongoing HIV 0.296069 recent HIV testing 0.394361 viral load 0.576693 higher HIV prevalence 0.311396 viral suppression 0.470411 HIV health-care 0.263633 HIV diagnosis 0.290144 HIV testing percentages 0.284307 HIV-related medical care 0.255122 Patient Care STDS 0.248542	ongoing HIV care 0.293144 HIV Prevention Conference 0.295659 HIV incidence 0.275473 early HIV 0.25243 hiv prevention 0.325381 HIV prevention services 0.271531 name-based HIV infection 0.262166 HIV medical care 0.501788 medical care 0.657119 HIV care providers 0.316114 routine HIV screening 0.256808 HIV care 0.558237 persons 0.546422 HIV screening 0.261715 lifetime HIV treatment 0.254671 HIV 0.958405 HIV prevention interventions 0.288815 HIV viral load 0.392466 National HIV Prevention 0.294308 HIV testing 0.49526 human immunodeficiency virus 0.33825 consistently suppressed HIV 0.291725 HIV infection 0.518833	CLICK HERE
7203	Centers for Disease Control and Prevention	Html	en	Unexplained Respiratory Disease Outbreak Working Group Activities - Worldwide, March 2007-September 2011	Persons using assistive technology might not be able to fully access information in this file. For assistance, please send e-mail to: mmwrq@cdc.gov.	epidemiologic information 0.461535 CDC 0.4934 Mycoplasma pneumoniae 0.524722 unexplained respiratory disease 0.952142 sample respiratory illness 0.503883 on-site epidemiologic investigation 0.467079 respiratory disease investigations 0.537367 commonly identified etiologies 0.477684 group 0.603812 respiratory specimens 0.503664 disease outbreak investigations 0.501383 CDC response efforts 0.474322 respiratory disease outbreaks 0.755464 Bordetella pertussis 0.525292 etiologies 0.481582 public health officials 0.742063 epidemiologic investigations 0.483231 noninfluenza respiratory viruses 0.59835 international public health 0.558359 TaqMan Array Cards 0.598017 public health response 0.470699 respiratory disease investigation 0.515139 illness onset 0.530285 optimal respiratory specimens 0.499682	median case number 0.469316 respiratory syncytial virus 0.505729 respiratory component 0.486577 commonly implicated pathogens 0.464898 United States 0.510768 early laboratory specimens 0.466886 investigations 0.633794 wild-type poliovirus outbreak 0.466868 URDO 0.564753 Respiratory Diseases Br 0.51076 respiratory symptoms 0.482354 respiratory pathogens 0.532041 public health professionals 0.460969 Katherine E. Fleming-Dutra 0.486228 on-site field investigation 0.499913 noninfectious respiratory diseases 0.529403 respiratory disease outbreak 0.677466 Common respiratory pathogens 0.514584 Outbreak Working Group 0.51213 local public health 0.500069 etiology 0.500511 influenza viruses 0.513753 public health responses 0.46332 unexplained respiratory outbreaks 0.614283	CLICK HERE
9646	Centers for Disease Control and Prevention	Html	en	Announcements: Application Deadline for The CDC ExperienceApplied Epidemiology Fellowship - December 6, 2013	Persons using assistive technology might not be able to fully access information in this file. For assistance, please send e-mail to: mmwrq@cdc.gov.	mmwrq@cdc.gov. 0.596067 practical knowledge 0.574562 endorsement 0.488099 clinical acumen 0.583494 Human Services 0.719756 analytic thinking 0.571981 assistive technology 0.599534 U.S. Department 0.712061 MMWR HTML versions 0.698695 skills 0.456319 electronic PDF version 0.686332 e-mail 0.462059 fourth-year medical students 0.732903 Contact GPO 0.597592 population-based health problems 0.758056 commercial sources 0.56684 current prices 0.559587 epidemiologic analyses 0.585903 original paper copy 0.696033 program coordinator 0.56953 U.S. Government Printing 0.705285 original MMWR paper 0.692522 preventive medicine 0.575723 oral scientific presentations 0.721218	Superintendent 0.432454 Virginia Watson 0.565989 competitively selected fellows 0.758848 assistance 0.431423 title 0.431147 CDC Experience 0.90758 1-year fellowship 0.600654 MMWR readers 0.571604 character translation 0.558066 epidemiology 0.469325 file 0.431597 Persons 0.431707 public health 0.703975 format errors 0.561174 subject line 0.592408 typeset documents 0.567899 trade names 0.566972 paper copy 0.708541 official text 0.555973 U.S. health-care 0.588156 non-CDC sites 0.564165 information 0.458952 Accommodation 0.431171 electronic conversions 0.55573	CLICK HERE
12437	Centers for Disease Control and Prevention	Html	en	Preventing Chronic Disease | Chronic Diseases, Lack of Medications, and Depression Among Syrian Refugees in Jordan, 2013"2014 - CDC	Preventing Chronic Disease (PCD) is a peer-reviewed electronic journal established by the National Center for Chronic Disease Prevention and Health Promotion. PCD provides an open exchange on the very latest in chronic disease prevention, research findings, public health interventions, and the exploration of new theories and concepts.	low effect size 0.56529 Jordan higher management 0.556687 study participants 0.555699 data 0.572614 depression scores 0.618276 mental health 0.614865 Caritas workers 0.572474 beck depression inventory 0.659911 significant association 0.546905 medication shortages 0.560045 chronic disease rates 0.585355 depression tendency 0.584261 chronic medical needs 0.578949 logistic regression 0.571897 eligible refugees 0.551027 Caritas Jordan 0.560806 chronic disease type 0.582567 depression categories 0.608944 significant depression 0.60901 depression rates 0.570051 chronic disease 0.733112 Syrian refugees 0.847957 depression risk 0.570154 basic life needs 0.568664 depression prevalence 0.639734	Direct logistic regression 0.562939 study 0.622652 United States 0.550466 depression severity 0.571141 Iraqi refugees 0.546943 chronic disease records 0.582681 physical health problems 0.576814 medication availability 0.644323 study data collection 0.554941 Jordan 0.665313 health care 0.592941 participants 0.63296 depression comorbidity 0.585708 chronic diseases 0.985139 refugees facilitates 0.556923 depression status 0.578761 demographic data 0.550647 previous chronic disease 0.587802 data collection 0.565663 total depression scores 0.59039 chronic conditions 0.565058 Chronic disease presence 0.583848 priority chronic diseases 0.591842 Chronic disease prevalence 0.58949	CLICK HERE
12658	Centers for Disease Control and Prevention	Video	en	Baby Steps: Learn the Signs. Act Early	Learn how to look for developmental milestones in your young child and what to do if you have a concern about your child's development. Comments on this video are allowed in accordance with our comment policy: http://www.cdc.gov/SocialMedia/Tools/CommentPolicy.html This video can also be viewed at http://www.cdc.gov/NCBDDD/actearly/multimedia/video.html	Signs 0.644739 Baby 0.655077	Act Early. 0.943437	CLICK HERE
13789	Centers for Disease Control and Prevention	Html	en	Use of Serogroup B Meningococcal Vaccines in Adolescents andYoung Adults: Recommendations of the Advisory Committee onImmunization Practices, 2015	Recommendations for routine use of vaccines in children, adolescents, and adults are developed by the Advisory Committee on Immunization Practices (ACIP). ACIP is chartered as a federal advisory committee to provide expert external advice and guidance to the Director of the Centers for Disease Control and Prevention (CDC) on use of vaccines and related agents for the control of vaccine-preventable diseases in the civilian population of the United States. Recommendations for routine use of vaccines in children and adolescents are harmonized to the greatest extent possible with recommendations made by the American Academy of Pediatrics (AAP), the American Academy of Family Physicians (AAFP), and the American College of Obstetricians and Gynecologists (ACOG).	United States 0.498488 meningococcal disease cases 0.220662 meningococcal disease epidemiology 0.245449 Vaccines Work Group 0.330495 strains 0.274668 geometric mean titer 0.217331 Immunization Practices 0.201488 safety data 0.285563 composite response 0.311309 college students 0.269873 meningococcal conjugate vaccine 0.245785 meningococcal disease incidence 0.24507 Practices Meningococcal Vaccines 0.278547 clinical trials 0.694644 ACIP Meningococcal Vaccines 0.477545 meningococcal strains 0.218758	selected meningococcal serogroup 0.316088 MenB-FHbp 0.220662 adolescents 0.22031 meningococcal conjugate vaccines 0.313582 Serogroup B Meningococcal 0.306087 unpublished data 0.498631 adverse events 0.415493 MenB vaccines 0.813867 vaccine effectiveness 0.223525 meningococcal disease 0.969073 serogroup 0.434871 young adults 0.629858 MenB-4C 0.209315 mean titer ratio 0.218095 Meningococcal Vaccines Work 0.427287	CLICK HERE